The worsening renal failure in a chronic cardio-renal syndrome type II: efficacy of a single levosimendan infusion

Minerva Cardioangiol. 2016 Dec;64(6):703-704.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Cardio-Renal Syndrome / complications*
  • Disease Progression
  • Humans
  • Hydrazones / administration & dosage
  • Hydrazones / therapeutic use*
  • Infusions, Intravenous
  • Male
  • Pyridazines / administration & dosage
  • Pyridazines / therapeutic use*
  • Renal Insufficiency / drug therapy*
  • Renal Insufficiency / etiology
  • Simendan
  • Treatment Outcome
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / therapeutic use*

Substances

  • Hydrazones
  • Pyridazines
  • Vasodilator Agents
  • Simendan